GRAIL is trading at $76.68, down -4.15%, with no clear company-specific catalyst directly explaining the decline.
- No new GRAIL announcement dated August 31, 2026 appears on the company’s investor-relations release list; the latest listed releases are August 7 and August 5.
- Broader markets are modestly lower, with recent pressure centered on biotech sentiment and interest-rate concerns.
- Monitor the move for delayed news.